Skip to main content
Top

Open Access 20-01-2023 | Shock

Intermuscular two-incision technique for implantation of the subcutaneous implantable cardioverter defibrillator: a 3-year follow-up

Authors: Federico Migliore, Raimondo Pittorru, Enrico Giacomin, Pietro Bernardo Dall’Aglio, Pasquale Valerio Falzone, Emanuele Bertaglia, Sabino Iliceto, Dario Gregori, Manuel De Lazzari, Domenico Corrado

Published in: Journal of Interventional Cardiac Electrophysiology

Login to get access

Abstract

Purpose

The aim of the present study was to evaluate the outcome of patients underwent subcutaneous implantable cardioverter defibrillator (S-ICD) implantation with the intermuscular (IM) two-incision technique during 3-year follow-up.

Methods

the study population consisted of 105 consecutive patients (79 male; median 50 [13–77] years) underwent S-ICD implantation with the IM two-incision technique. The composite primary end point of the study consisted of device-related complications and inappropriate shocks (IAS). Secondary end points included the individual components of the primary end point, death from any cause, appropriate therapy, major adverse cardiac events, hospitalization for heart failure, and heart transplantation.

Results

According to the PRAETORIAN score, the risk of conversion failure was classified as low in 99 patients (94.3%), intermediate in 6 (5.7%).Ventricular fibrillation was successfully converted at ≤65 J in 97.4% of patients. During a median follow-up of 39 (16–53) months, 10 patients (9.5%) experienced device-related complications, and 9 (8.5%) patients reported IAS. Lead-associated complications were the most common (5 patients, 4.7%), including 2 cases of lead failure (1.9%). Pocket complications were reported in 2 patients (1.9%). Extra-cardiac oversensing (3.8%) represented the leading cause of IAS. No T-wave oversensing episodes were recorded. Twelve patients (11.4%) experienced appropriate shocks. Eight patients (7.6%) died during follow-up. IAS or device-related complications did not impact on mortality.

Conclusions

The overall device-related complications and IAS rates over 3 years of follow-up were 9.5% and 8.5%, respectively. According to our findings, the IM two-incision technique allows for optimal positioning of the device achieving a low PRAETORIAN score with a high conversion rate. IM two-incision technique allows low incidence of pocket complications, shifting the type of complications towards lead-related complications, which represent the most common complications. The IM two-incision technique would not seem to impact the occurrence of IAS. Management of complications are safe without impact on the outcome.
Appendix
Available only for authorised users
Literature
1.
go back to reference Knops RE, Olde Nordkamp LRA, Delnoy PHM, et al. Subcutaneous or transvenous defibrillator therapy. N Engl J Med. 2020;383:526–36.CrossRef Knops RE, Olde Nordkamp LRA, Delnoy PHM, et al. Subcutaneous or transvenous defibrillator therapy. N Engl J Med. 2020;383:526–36.CrossRef
2.
go back to reference Gold MR, Lambiase PD, El-Chami MF, Knops RE, Aasbo JD, Bongiorni MG. Primary results from the understanding outcomes with the S-ICD in primary prevention patients with low ejection fraction (UNTOUCHED) Trial. Circulation. 2021;143:7–17.CrossRef Gold MR, Lambiase PD, El-Chami MF, Knops RE, Aasbo JD, Bongiorni MG. Primary results from the understanding outcomes with the S-ICD in primary prevention patients with low ejection fraction (UNTOUCHED) Trial. Circulation. 2021;143:7–17.CrossRef
3.
go back to reference Migliore F, Viani S, Bongiorni MG, et al. Subcutaneous implantable cardioverter defibrillator in patients with arrhythmogenic right ventricular cardiomyopathy: Results from an Italian multicenter registry. Int J Cardiol. 2019;280:74–9.CrossRef Migliore F, Viani S, Bongiorni MG, et al. Subcutaneous implantable cardioverter defibrillator in patients with arrhythmogenic right ventricular cardiomyopathy: Results from an Italian multicenter registry. Int J Cardiol. 2019;280:74–9.CrossRef
4.
go back to reference Migliore F, Allocca G, Calzolari V, et al. Intermuscular two-incision technique for subcutaneous implantable cardioverter defibrillator implantation: results from a multicenter registry. Pacing Clin Electrophysiol. 2017;40:278–85.CrossRef Migliore F, Allocca G, Calzolari V, et al. Intermuscular two-incision technique for subcutaneous implantable cardioverter defibrillator implantation: results from a multicenter registry. Pacing Clin Electrophysiol. 2017;40:278–85.CrossRef
5.
go back to reference Winter J, Siekiera M, Shin DI, et al. Intermuscular technique for implantation of the subcutaneous implantable cardioverter defibrillator: long-term performance and complications. Europace. 2017;19:2036–41.CrossRef Winter J, Siekiera M, Shin DI, et al. Intermuscular technique for implantation of the subcutaneous implantable cardioverter defibrillator: long-term performance and complications. Europace. 2017;19:2036–41.CrossRef
6.
go back to reference Heist EK, Stahl W, Belalcazar A. Impact of generator location and sub-coil fat on 286 subcutaneous-ICD defibrillation thresholds. Heart Rhythm. 2017;14(5 Suppl 1):S102. Heist EK, Stahl W, Belalcazar A. Impact of generator location and sub-coil fat on 286 subcutaneous-ICD defibrillation thresholds. Heart Rhythm. 2017;14(5 Suppl 1):S102.
7.
go back to reference Quast A-FBE, Baalman SWE, Brouwer TF, et al. A novel tool to evaluate the implant position and predict defibrillation success of the subcutaneous implantable defibrillator: the PRAETORIAN score. Heart Rhythm. 2019;16:403–10.CrossRef Quast A-FBE, Baalman SWE, Brouwer TF, et al. A novel tool to evaluate the implant position and predict defibrillation success of the subcutaneous implantable defibrillator: the PRAETORIAN score. Heart Rhythm. 2019;16:403–10.CrossRef
8.
go back to reference Francia P, Biffi M, Adduci C, et al. Implantation technique and optimal subcutaneous defibrillator chest position: a PRAETORIAN score-based study. Europace. 2020;22:1822–9.CrossRef Francia P, Biffi M, Adduci C, et al. Implantation technique and optimal subcutaneous defibrillator chest position: a PRAETORIAN score-based study. Europace. 2020;22:1822–9.CrossRef
9.
go back to reference Viani S, Migliore F, Ottaviano L, et al. Longevity of model 3501 subcutaneous implantable cardioverter-defibrillator leads in clinical practice. Heart Rhythm. 2022;S1547-5271(22):00225–9. Viani S, Migliore F, Ottaviano L, et al. Longevity of model 3501 subcutaneous implantable cardioverter-defibrillator leads in clinical practice. Heart Rhythm. 2022;S1547-5271(22):00225–9.
11.
go back to reference Amin AK, Gold MR, Burke MC, et al. Factors associated with high-voltage impedance and subcutaneous implantable defibrillator ventricular fibrillation conversion success. Circ Arrhythm Electrophysiol. 2019;12:e006665.CrossRef Amin AK, Gold MR, Burke MC, et al. Factors associated with high-voltage impedance and subcutaneous implantable defibrillator ventricular fibrillation conversion success. Circ Arrhythm Electrophysiol. 2019;12:e006665.CrossRef
12.
go back to reference Migliore F, Mattesi G, De Franceschi P, et al. Multicentre experience with the second-generation subcutaneous implantable cardioverter defibrillator and the intermuscular two-incision implantation technique. J Cardiovasc Electrophysiol. 2019;30:854–64.CrossRef Migliore F, Mattesi G, De Franceschi P, et al. Multicentre experience with the second-generation subcutaneous implantable cardioverter defibrillator and the intermuscular two-incision implantation technique. J Cardiovasc Electrophysiol. 2019;30:854–64.CrossRef
13.
go back to reference Okabe T, Savona SJ, Matto F, et al. A 10 J shock impedance in sinus rhythm correlates with a 65 J defibrillation impedance during subcutaneous defibrillator implantation using an intermuscular technique. J Cardiovasc Electrophysiol. 2021;32:3027–34.CrossRef Okabe T, Savona SJ, Matto F, et al. A 10 J shock impedance in sinus rhythm correlates with a 65 J defibrillation impedance during subcutaneous defibrillator implantation using an intermuscular technique. J Cardiovasc Electrophysiol. 2021;32:3027–34.CrossRef
14.
go back to reference Quast A, Baalman SWE, Betts TR, et al. Rationale and design of the PRAETORIAN-DFT trial: a prospective randomized CompArative trial of SubcutanEous ImplanTable CardiOverter-DefibrillatoR ImplANtation with and without DeFibrillation testing. Am Heart J. 2019;214:167–74.CrossRef Quast A, Baalman SWE, Betts TR, et al. Rationale and design of the PRAETORIAN-DFT trial: a prospective randomized CompArative trial of SubcutanEous ImplanTable CardiOverter-DefibrillatoR ImplANtation with and without DeFibrillation testing. Am Heart J. 2019;214:167–74.CrossRef
15.
go back to reference Olde Nordkamp LR, Dabiri Abkenari L, Boersma LV, et al. The entirely subcutaneous implantable cardioverterdefibrillator: initial clinical experience in a large Dutch cohort. J Am Coll Cardiol. 2012;60:1933–9.CrossRef Olde Nordkamp LR, Dabiri Abkenari L, Boersma LV, et al. The entirely subcutaneous implantable cardioverterdefibrillator: initial clinical experience in a large Dutch cohort. J Am Coll Cardiol. 2012;60:1933–9.CrossRef
16.
go back to reference Lambiase PD, Theuns DA, Murgatroyd F, et al. Subcutaneous implantable cardioverter-defibrillators: long-term results of the EFFORTLESS study. Eur Heart J. 2022;43:2037–50.CrossRef Lambiase PD, Theuns DA, Murgatroyd F, et al. Subcutaneous implantable cardioverter-defibrillators: long-term results of the EFFORTLESS study. Eur Heart J. 2022;43:2037–50.CrossRef
17.
go back to reference Gasperetti A, Schiavone M, Ziacchi M, et al. Long-term complications in patients implanted with subcutaneous implantable cardioverter-defibrillators: real-world data from the extended ELISIR experience. Heart Rhythm. 2021;18:2050–8.CrossRef Gasperetti A, Schiavone M, Ziacchi M, et al. Long-term complications in patients implanted with subcutaneous implantable cardioverter-defibrillators: real-world data from the extended ELISIR experience. Heart Rhythm. 2021;18:2050–8.CrossRef
18.
go back to reference Gulletta S, Gasperetti A, Schiavone M, et al. Age-related differences and associated mid-term outcomes of subcutaneous implantable cardioverter-defibrillators: a propensity-matched analysis from a multicenter European registry. Heart Rhythm. 2022;S1547-5271(22):00214–4. Gulletta S, Gasperetti A, Schiavone M, et al. Age-related differences and associated mid-term outcomes of subcutaneous implantable cardioverter-defibrillators: a propensity-matched analysis from a multicenter European registry. Heart Rhythm. 2022;S1547-5271(22):00214–4.
Metadata
Title
Intermuscular two-incision technique for implantation of the subcutaneous implantable cardioverter defibrillator: a 3-year follow-up
Authors
Federico Migliore
Raimondo Pittorru
Enrico Giacomin
Pietro Bernardo Dall’Aglio
Pasquale Valerio Falzone
Emanuele Bertaglia
Sabino Iliceto
Dario Gregori
Manuel De Lazzari
Domenico Corrado
Publication date
20-01-2023